semaglutide non injection GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns Semaglutide NYC Weight Loss Program

With Semaglutide and other medical therapies, we can help you lose weight quickly and safely.

Learn about its mild to serious side effects and what to do about them.

Why Choose WeightCare: Board-certified physicians No in-person visits required Comprehensive support system Evidence-based approach Personal Member Success Advocate

GLP-1 Medications Explained: A Doctor's Guide to Effective Weight Loss

CagriSema is a fixed-dose combination of cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist), and is currently an experimental obesity drug developed by Novo Nordisk

This webinar with obesity medicine physician Jonathan Bonnet, MD, MPH, a GLP-1RA expert, will answer all your questions about the medications, how they work, their benefits, their side effects, and how they can be combined with lifestyle changes to optimize your weight loss and body composition.